Director, Survivorship Services, Winship Cancer Institute of Emory University
Co-Director, Breast Medical Oncology, Department of Hematology and Medical Oncology
Associate Professor, Department of Hematology and Medical Oncology
Emory University School of Medicine
Atlanta, GA
Stream the Case-Based Exchange Webinar: “High-Risk, Node-Positive, HR-Positive/HER2-Negative Early Breast Cancer” to hear perspectives on markers of high-risk disease and practical treatment approaches from Neil Iyengar, MD, and Annalise Labatut, PharmD, BCOP, of the Winship Cancer Institute of Emory University. Topics include the role of the CDK4/6 inhibitor in adjuvant treatment. Read More ›
Dr. Neil M. Iyengar, Associate Attending Physician at Memorial Sloan Kettering Cancer Center, highlights and addresses potential barriers of clinically and demographically underserved patients with HER2-positive mBC. Read More ›
Dr. Neil M. Iyengar, Associate Attending Physician at Memorial Sloan Kettering Cancer Center, discusses his perspectives on the current treatment landscape and clinical management of HER2-positive mBC. Read More ›
Dr. Neil M. Iyengar, Associate Attending Physician at Memorial Sloan Kettering Cancer Center, reports on current trials in progress in patients with HER2-positive mBC with and without the presence of brain metastasis. Read More ›
